Search Press releases

Press releases teaser image
9 May 2025

RYSTIGGO[®] (rozanolixizumab) receives approval in Japan for two new administration methods as UCB begins ONWARD program for patient support

Read More
Press releases teaser image
24 Apr 2025

UCB’s General Meeting of Shareholders 2025

Read More
Press releases teaser image
11 Apr 2025

Global data show real-world effectiveness of romosozumab for patients at high fracture risk

Read More
Press releases teaser image
4 Apr 2025

Acquisition of own shares

Read More
Press releases teaser image
3 Apr 2025

UCB presents latest research across leading neurology portfolio at American Academy of Neurology (AAN) meeting 2025

Read More
Press releases teaser image
1 Apr 2025

UCB presents key data from Alzheimer’s and Parkinson’s disease research programs at AD/PD 2025

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe